CAM-H2 production at Evergreen marks the expansion of Precirix’ clinical trial to the US

Brussels, Belgium and New Jersey, US – 08 June 2023 – Precirix, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announced the production of a first clinical trial batch of CAM-H2 at Evergreen Theragnostics’ state-of-the-art facility in Springfield, NJ (US). Precirix is currently running a Phase I/II clinical trial in Canada to evaluate …